TrianglePUBLICATIONS · 18645194
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 Oct 10
- First author
- Reece DE
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Reece DE
- type
- Author
- name
- Rodriguez GP
- type
- Author
- name
- Chen C
- type
- Author
- name
- Trudel S
- type
- Author
- name
- Kukreti V
- type
- Author
- name
- Mikhael J
- type
- Author
- name
- Pantoja M
- type
- Author
- name
- Xu W
- type
- Author
- name
- Stewart AK
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Reece DE
- type
- Author
- name
- Rodriguez GP
- type
- Author
- name
- Chen C
- type
- Author
- name
- Trudel S
- type
- Author
- name
- Kukreti V
- type
- Author
- name
- Mikhael J
- type
- Author
- name
- Pantoja M
- type
- Author
- name
- Xu W
- type
- Author
- name
- Stewart AK
- type
- Author
- bibliography ids
- nci-bib-d9cabaea03e266059c410765
- book metadata
- content sha256
- 0875bcc9088fd7744ae4a8be8dce3264a1f0378c873008d23890caee768c3005
- document type
- citation
- dois
- 10.1200/JCO.2007.14.2372
- electronic publication date
- display
- 2008 Jul 21
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18645194
- immutable id
- pubmed:18645194@0875bcc9088fd7744ae4a8be8dce3264a1f0378c873008d23890caee768c3005
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 29
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4777-83
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18645194
- provenance
- batch id
- 6281e3e555c9a831cffc
- provider
- NCBI PubMed ESummary
- record sha256
- 21c08e216eb60eedbcba03a25221bfb3b3ad05d6077983136a2f11c997950d95
- response sha256
- 0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
- retrieved at
- 2026-09-09T23:46:21.772457+00:00
- publication date
- display
- 2008 Oct 10
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma.
Preserved source evidence · Not medical advice